Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
genentech
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
boston
cancer
eli lilly
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
boulder/denver blog main
boulder/denver top stories
breast
bristol-myers squibb
cancer drugs
capmatinib
celgene
clinical trials
combinations
conference
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
esmo
esmo 2018
europe blog main
europe top stories
What
cancer
3
×
approval
blueprint
drug
fda
medicines
ret
address
annual
approves
breast
cancer's
candidate
carries
certain
clinical
conference
currently
data
designed
esmo
european
genetic
latest
lines
lung
marketing
medical
meds
muscle
oncology
pact
pass
precision
regulatory
replete
review
roche
signature
signatures
Language
unset
Current search:
genentech
×
cancer
×
roche
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front